Burgoyne AM - Search Results

1

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL. Burgoyne AM, et al. Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. eCollection 2020. Cell Discov. 2020. PMID: 32793389 Free PMC article. No abstract available.

2

[No title available]

[No authors listed] [No authors listed] PMID: 34315865

3

Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.

Singh AR, Joshi S, Burgoyne AM, Sicklick JK, Ikeda S, Kono Y, Garlich JR, Morales GA, Durden DL. Singh AR, et al. Among authors: burgoyne am. Mol Cancer Ther. 2016 Nov;15(11):2553-2562. doi: 10.1158/1535-7163.MCT-15-0976. Epub 2016 Aug 5. Mol Cancer Ther. 2016. PMID: 27496136 Free PMC article.

4

Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets.

Vann KR, Pal D, Morales GA, Burgoyne AM, Durden DL, Kutateladze TG. Vann KR, et al. Among authors: burgoyne am. Sci Rep. 2020 Jul 21;10(1):12027. doi: 10.1038/s41598-020-68964-6. Sci Rep. 2020. PMID: 32694708 Free PMC article.

5

Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. Murphy JD, et al. Among authors: burgoyne am. Cancer. 2015 Sep 1;121(17):2960-7. doi: 10.1002/cncr.29434. Epub 2015 Apr 30. Cancer. 2015. PMID: 25930983 Free PMC article.

6

Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers.

Okamura R, Kurzrock R, Mallory RJ, Fanta PT, Burgoyne AM, Clary BM, Kato S, Sicklick JK. Okamura R, et al. Among authors: burgoyne am. Int J Cancer. 2021 Feb 1;148(3):702-712. doi: 10.1002/ijc.33230. Epub 2020 Aug 28. Int J Cancer. 2021. PMID: 32700810 Free PMC article.

7

Gastrointestinal stromal tumors in the setting of multiple tumor syndromes.

Burgoyne AM, Somaiah N, Sicklick JK. Burgoyne AM, et al. Curr Opin Oncol. 2014 Jul;26(4):408-14. doi: 10.1097/CCO.0000000000000089. Curr Opin Oncol. 2014. PMID: 24840526 Review.

8

Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.

Tang CM, Lee TE, Syed SA, Burgoyne AM, Leonard SY, Gao F, Chan JC, Shi E, Chmielecki J, Morosini D, Wang K, Ross JS, Kendrick ML, Bardsley MR, Siena M, Mao J, Harismendy O, Ordog T, Sicklick JK. Tang CM, et al. Among authors: burgoyne am. Oncotarget. 2016 Nov 29;7(48):78226-78241. doi: 10.18632/oncotarget.12909. Oncotarget. 2016. PMID: 27793025 Free PMC article.

9

Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.

Yoon H, Tang CM, Banerjee S, Yebra M, Noh S, Burgoyne AM, Torre J, Siena M, Liu M, Klug LR, Choi YY, Hosseini M, Delgado AL, Wang Z, French RP, Lowy A, DeMatteo RP, Heinrich MC, Molinolo AA, Gutkind JS, Harismendy O, Sicklick JK. Yoon H, et al. Among authors: burgoyne am. Oncogene. 2021 Mar;40(11):1957-1973. doi: 10.1038/s41388-021-01685-w. Epub 2021 Feb 18. Oncogene. 2021. PMID: 33603171 Free PMC article.

10

A Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy.

Charo LM, Burgoyne AM, Fanta PT, Patel H, Chmielecki J, Sicklick JK, McHale MT. Charo LM, et al. Among authors: burgoyne am. J Natl Compr Canc Netw. 2018 Mar;16(3):238-242. doi: 10.6004/jnccn.2017.7039. J Natl Compr Canc Netw. 2018. PMID: 29523662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page